drugset / Trial / NCT06077786
A Trial Investigating the Pain-relieving Properties of Lu AG06474 in Healthy Adult Participants
RandomizedCrossoverDouble-blindTreatment
Summary
The main goal of this trial is to learn about the effect of Lu AG06474 on a battery of Evoked Pain Tests when a single dose is given to healthy adult participants. The effects of Lu AG06474 will be compared with 2 approved pain-relieving medications (ibuprofen and pregabalin) and with a placebo (a treatment that looks like the trial treatment but does not have any medicine in it). Each participant will receive 1 dose of each of these treatments during the trial (Lu AG06474, ibuprofen, pregabalin, and placebo), with 1 week between treatments. All treatments will be taken orally (by mouth), either as a liquid or a capsule.
Timeline
- Start
- 2023-10-13
- Primary completion
- 2024-05-10
- Completion
- 2024-05-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ibuprofen | Small molecule | — | Oral |
| Subject | Lu AG06474 | Unknown | — | Oral |
| Subject | Pregabalin | Small molecule | — | Oral |
Indications
No indication recorded.